Increased Th2-like invariant natural killer T cells in peripheral blood from patients with asthma

Allergy, Asthma and Immunology Research

Volumn 6, Issue 5, 2014, Pages 444-448

  Shim, Jae Uoong ^a   Koh, Young Il ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Asthma; Natural killer T cell; Th2 cytokines

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONOCLONAL ANTIBODY; THEOPHYLLINE;

ADULT; ARTICLE; ASTHMA; CASE CONTROL STUDY; CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; INVARIANT NATURAL KILLER T CELL; LUNG FUNCTION; MALE; MIDDLE AGED; NATURAL KILLER T CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTIVE VALUE; STAINING; T LYMPHOCYTE SUBPOPULATION; TH2 CELL;

EID: 84906957231     PISSN: 20927355     EISSN: 20927363     Source Type: Journal    
DOI: 10.4168/aair.2014.6.5.444     Document Type: Article

References (20)

1. National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol 2007; 120:S94-138.
2. Umetsu DT, DeKruyff RH. A role for natural killer T cells in asthma. Nat Rev Immunol 2006;6:953-8.
3. Kronenberg M, Gapin L. The unconventional lifestyle of NKT cells. Nat Rev Immunol 2002;2:557-68.
4. Akbari O, Stock P, Meyer E, Kronenberg M, Sidobre S, Nakayama T, Taniguchi M, Grusby MJ, DeKruyff RH, Umetsu DT. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 2003;9:582-8.
5. Meyer EH, Goya S, Akbari O, Berry GJ, Savage PB, Kronenberg M, Nakayama T, DeKruyff RH, Umetsu DT. Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells. Proc Natl Acad Sci USA 2006;103:2782-7.
6. Pichavant M, Goya S, Meyer EH, Johnston RA, Kim HY, Matangkasombut P, Zhu M, Iwakura Y, Savage PB, DeKruyff RH, Shore SA, Umetsu DT. Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17. J Exp Med 2008;205:385-93.
7. Koh YI, Kim HY, Meyer EH, Pichavant M, Akbari O, Yasumi T, Savage PB, Dekruyff RH, Umetsu DT. Activation of nonclassical CD1d-restricted NK T cells induces airway hyperreactivity in beta 2-microglobulin-deficient mice. J Immunol 2008;181:4560-9.
8. Akbari O, Faul JL, Hoyte EG, Berry GJ, Wahlstro¨m J, Kronenberg M, DeKruyff RH, Umetsu DT. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N Engl J Med 2006;354:1117-29.
9. Vijayanand P, Seumois G, Pickard C, Powell RM, Angco G, Sammut D, Gadola SD, Friedmann PS, Djukanovic R. Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. N Engl J Med 2007;356:1410-22.
10. Koh YI, Shim JU. Association between sputum natural killer T cells and eosinophilic airway inflammation in human asthma. Int Arch Allergy Immunol 2010;153:239-48.
11. Koh YI, Shim JU, Wi J, Kwon YE. The role of natural killer T cells in the pathogenesis of acute exacerbation of human asthma. Int Arch Allergy Immunol 2012;158:131-41.
12. Koh YI, Shim JU, Wi JO, Han ER, Jin NC, Oh SH, Park CK, Park DJ. Inverse association of peripheral blood CD4(+) invariant natural killer T cells with atopy in human asthma. Hum Immunol 2010;71: 186-91.
13. Brennan PJ, Brigl M, Brenner MB. Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat Rev Immunol 2013;13:101-17.
14. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. Interpretative strategies for lung function tests. Eur Respir J 2005;26:948-68.
15. Global Initiative For Asthma. Global strategy for asthma management and prevention. Bethesda, national Institutes of Health/National Heart, Lung, and Blood Institute, Global Initiative For Asthma; 2006.
16. Reynolds C, Barkans J, Clark P, Kariyawasam H, Altmann D, Kay B, Boyton R. Natural killer T cells in bronchial biopsies from human allergen challenge model of allergic asthma. J Allergy Clin Immunol 2009;124:860-2.
17. Yan-ming L, Lan-fang C, Chen L, Ya-qin L, Wei C, Wen-ming Z. The effect of specific immunotherapy on natural killer T cells in peripheral blood of house dust mite-sensitized children with asthma. Clin Dev Immunol 2012;2012:148262.
18. Carpio-Pedroza JC, Vaughan G, del Rio-Navarro BE, del Ri´o-Chivardi´ JM, Vergara-Castañeda A, Jime´nez-Zamudio LA, Morales-Flores A, Rodri´guez-Moreno G, Ruiz-Tovar K, Fonseca-Coronado S, Gonc¸alves Rossi LM, Escobar-Gutie´rrez A. Participation of CD161(+) and invariant natural killer T cells in pediatric asthma exacerbations. Allergy Asthma Proc 2013;34:84-92.
19. Terashima A, Watarai H, Inoue S, Sekine E, Nakagawa R, Hase K, Iwamura C, Nakajima H, Nakayama T, Taniguchi M. A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity. J Exp Med 2008;205: 2727-33.
20. Bosma A, Abdel-Gadir A, Isenberg DA, Jury EC, Mauri C. Lipid-antigen presentation by CD1d(+) B cells is essential for the maintenance of invariant natural killer T cells. Immunity 2012;36:477-90.